Skip to main content
. 2014 Nov 13;13(2):184–196. doi: 10.2450/2014.0174.14

Table III.

PARV4 DNA findings by PCR in blood donors or plasma-derived medicinal products.

PARV4 DNA (%) Subjects of study Study author and year of publication
5.1 Plasma donations Fryer JF, 2006142

  1. 8.7

  2. 4

  1. Healthy donors, febrile patients, IDUs,

  2. plasma pools

 Fryer JF, 2007130
16
pre-1990 23%
1990–2005 2%		 Factor VIII concentrates collected from 1974 to 2005 Fryer JF, 2007134
11.5 HCV positive subjects and/or IDU Fryer JF, 2007138
5.3 IDU, blood donors negative for HIV, HCV and HBV Lurcharchaiwong W, 2008141
12.4 Coagulation factor concentrates Schneider B, 2008135

  1. 1

  2. 1.2

  3. 0

  4. 1.6

  1. Blood donors,

  2. patients with suspected viral diseases,

  3. BM/PBSC transplant recipients,

  4. kidney transplant recipients

 Vallerini D, 2008143
3.8 Healthy blood and skin donors, skin donors with dermatological disease Botto S, 2009144
0 Transfused immunocompetent patients, blood donors Servant-Delmas A, 2009145
1.7 HCV, HIV, and HBV positive subjects Tuke PW, 2010146
8.6 Infants (Ghana) Panning M, 2010147
24 Blood donors Touinssi M, 2010148
24.5 Haemodialysis patients positive or not for HBV markers, lung transplant recipients Touinssi M, 2011149
26 Plasma donations Modrow S, 201165
26.15 Blood donors Ma YY, 2012133
0 (4.76 IgG) Blood donors Maple PA, 2013150

PCR: polymerase chain reaction; IDU: intravenous drug users; HIV: human immunodeficiency virus; HCV: hepatitis C virus; HBV: hepatitis B virus; BM: bone marrow; PBSC: peripheral blood stem cell; IgG: immunoglobin G.